To determine the contribution of NHE9 to tumor initiation in vivo, we performed orthotopic transplant of luciferase-expressing GBM 612 transfected with scramble RNA (control) or shNHE9 (KD) at low seed counts (1,000 and 3,000 cells). The gene discussed is SLC9A9; the disease is neoplasm.